We don’t usually invest in Alzheimer’s disease therapeutics, but we made a happy exception for Vigil Neuroscience. The company is developing both an antibody and a small molecule targeting the TREM2 receptor. TREM2 is found on the surface of microglia (the brain’s immune cells), and its activation helps microglia engage in brain tissue regeneration. We’ve… Continue reading Sanofi is acquiring our portfolio company for $470M!
Author: yasny
Our portfolio company is being acquired for $4.9 billion!
We met Alpine Immune Sciences (ALPN) in 2020 and decided to invest in 2021 when the company was valued at $10-$12 per share. Yesterday, Vertex Pharmaceuticals announced the decision to acquire Alpine at a price of $65 per share. Approximately 6 times in less than three years (~90% annually) – not bad, right? It’s amazing… Continue reading Our portfolio company is being acquired for $4.9 billion!